These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2352162)

  • 41. Effect of dosage form and formulation factors on the adherence of drugs to the esophagus.
    Marvola M; Rajaniemi M; Marttila E; Vahervuo K; Sothmann A
    J Pharm Sci; 1983 Sep; 72(9):1034-6. PubMed ID: 6631689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
    Tam SW; Sabolinski ML; Worcel M; Packer M; Cohn JN
    Clin Pharmacokinet; 2007; 46(10):885-95. PubMed ID: 17854237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diclofenac potassium 12.5 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative, bioavailability study versus diclofenac potassium 12.5 mg tablets.
    Kienzler JL; Gold M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):438-44. PubMed ID: 22677305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired oesophageal transit of capsule versus tablet formulations in the elderly.
    Perkins AC; Wilson CG; Blackshaw PE; Vincent RM; Dansereau RJ; Juhlin KD; Bekker PJ; Spiller RC
    Gut; 1994 Oct; 35(10):1363-7. PubMed ID: 7959187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The administration of L-thyroxine as soft gel capsule or liquid solution.
    Vita R; Fallahi P; Antonelli A; Benvenga S
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1103-11. PubMed ID: 24896369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tramadol SR Formulations : Pharmacokinetic Comparison of a Multiple-Units Dose (Capsule) versus a Single-Unit Dose (Tablet).
    Cnota PJ; Nowak H; Tagarro I; Erb K; Schürer M; Schulz HU; Maus J
    Clin Drug Investig; 2005; 25(7):435-43. PubMed ID: 17532685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers.
    Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS
    Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylphenidate bioavailability from two extended-release formulations.
    González MA; Pentikis HS; Anderl N; Benedict MF; DeCory HH; Dirksen SJ; Hatch SJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):175-84. PubMed ID: 11996212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation and dosage form design in drug-induced topical irritation of the gastrointestinal tract.
    Fara JW; Myrback RE
    Pharm Res; 1990 Jun; 7(6):616-20. PubMed ID: 2102665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo-in vitro correlations with various aspirin formulations.
    Alcorn GJ; Lücker PW; Procaccini RL; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):761-7. PubMed ID: 3448453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The comparative bioavailability of liquid, wax-matrix, and microencapsulated preparations of potassium chloride.
    Skoutakis VA; Acchiardo SR; Wojciechowski NJ; Carter CA; Melikian AP; Chremos AN
    J Clin Pharmacol; 1985; 25(8):619-21. PubMed ID: 4078031
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pharmacokinetic analysis of diclofenac potassium soft-gelatin capsule in patients after bunionectomy.
    Kowalski M; Stoker DG; Bon C; Moore KA; Boesing SE
    Am J Ther; 2010; 17(5):460-8. PubMed ID: 19531931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: In vitro/in vivo evaluation.
    El-Setouhy DA; Basalious EB; Abdelmalak NS
    Eur J Pharm Biopharm; 2015 Aug; 94():386-92. PubMed ID: 26086847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic comparison of an oral diclofenac potassium liquid-filled soft gelatin capsule with a diclofenac potassium tablet.
    Lissy M; Scallion R; Stiff DD; Moore K
    Expert Opin Pharmacother; 2010 Apr; 11(5):701-8. PubMed ID: 20187842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients.
    Kim YK; Kim A; Park SJ; Lee H
    Drug Des Devel Ther; 2017; 11():2861-2869. PubMed ID: 29033547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation.
    Hull MW; Harris M; Lima V; Guillemi S; Harrigan PR; Montaner JS
    J Clin Pharmacol; 2009 Feb; 49(2):155-61. PubMed ID: 19179294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the behaviour of tablet and capsule formulations in vivo.
    Hunter E; Fell JT; Sharma H
    J Pharm Pharmacol; 1981 Sep; 33(9):617-8. PubMed ID: 6117651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.